Filing Details

Accession Number:
0001209191-23-020401
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-21 19:41:03
Reporting Period:
2023-03-17
Accepted Time:
2023-03-21 19:41:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178879 Amicus Therapeutics Inc. FOLD Pharmaceutical Preparations (2834) 200422823
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1321402 Michael Raab C/O Amicus Therapeutics, Inc.
3675 Market Street
Philadelphia PA 19104
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-17 15,000 $3.32 64,420 No 4 M Direct
Common Stock Disposition 2023-03-17 4,408 $11.33 60,012 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (right to buy) Disposition 2023-03-17 15,000 $0.00 15,000 $3.32
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-06-13 No 4 M Direct
Footnotes
  1. All of the options were fully vested and exercisable as of the transaction date.